For people with peanut allergies, new treatments in the pipeline offer the promise of tolerating small amounts of the same allergen that threatens them. A new study found clues about which patients may succeed on oral immunotherapy. Will patients find the trade-offs palatable?
Peanut allergy advances stir excitement, caution
